Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent Diabetes
Hisao Ogawa(Kumamoto University Hospital), Hirotaka Watada(Juntendo University), Izuru Masuda(Takeda (Japan)), Hideaki Jinnouchi, Masako Waki(Shizuoka City Hospital), Hisao Mori, Yoshihiko Saito(National Archives and Records Administration), Seigo Sugiyama(Diabetes Care Center), Masahiro Sugawara(Nerima General Hospital), Minoru Yoshiyama(Osaka City University), Kunihiko Matsui(Kumamoto University)
Cited by 26
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673